Vicapsys Life Sciences, Inc
Vicapsys, based in Athens, GA, is dedicated to developing innovative therapies targeting chronic diseases by focusing on localized modulation of immune and inflammatory responses. The company's core technology revolves around CXCL12, a pleiotropic cytokine, aimed specifically at curing Type 1 diabetes and managing related complications like diabetic foot ulcers and peritoneal adhesions.
Generated from the website
See a problem?
You might also like
United States›Vicapsys Life Sciences, Inc
Partial Data by Infogroup (c) 2023. All rights reserved.